INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME
- 1 June 1999
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 28 (2) , 423-438
- https://doi.org/10.1016/s0889-8529(05)70078-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled StudyJournal of Clinical Endocrinology & Metabolism, 1998
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.Journal of Clinical Investigation, 1995
- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1995
- Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese womenJournal of Clinical Endocrinology & Metabolism, 1995
- Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretionEndocrine Reviews, 1995
- Defects in beta-cell function in functional ovarian hyperandrogenismJournal of Clinical Endocrinology & Metabolism, 1993
- Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndromeDiabetes, 1992
- Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM PatientsDiabetes Care, 1990
- Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988